MSB 1.78% $1.11 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-4

  1. 15,458 Posts.
    lightbulb Created with Sketch. 5553
    Not sure the statistics agree with you on that .... especially given another 1,847 people died on Tuesday 4th Jan from COVID-19 in the USA alone ?

    I think Mesoblast have a great case to lobby either the NIH or a new partner to fund this additional phase 3 COVID-19 ARDS trial that they propose to undertake this year ....

    ..... almost 4 million new COVID-19 cases in the last 7 days is likely to see hospitalisation and death numbers increase over the coming weeks based on previous lags from case number increases and the situations evolving in many states combined with the winter months now upon the USA

    I am all for the additional phase 3 COVID-19 ARDS trial as long as Mesoblast don't have to fund it


    https://www.worldometers.info/coronavirus/

    upload_2022-1-5_15-33-0.png

    https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table

    upload_2022-1-5_15-42-30.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
-0.020(1.78%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.12 $1.13 $1.09 $4.556M 4.141M

Buyers (Bids)

No. Vol. Price($)
2 9590 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.11 3132 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.